PROVIDER PROFILE · NPI 1023425386
Amanda FadenrechtFNP-C
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
463
Unique beneficiaries
—
Total services
952
Distinct HCPCS
12
Medicare payment
$46K
Peer benchmark
Total Medicare services vs. 3,071 Nurse Practitioner providers in CO — top quintile (cohort median 233).
PRESCRIBING · PART D · 2024
Total Rx claims
2,386
Beneficiaries
—
Total drug cost
$274K
Distinct drugs
71
Brand share
17.3%
Top prescribed drugs
Levothyroxine Sodium202 claims
Omeprazole118 claims
Lisinopril114 claims
Losartan Potassium99 claims
Amlodipine Besylate92 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$969
Payment records
49
By payment type
Food and Beverage$969
Top paying entities
Food and Beverage$969
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
REFERRAL NETWORK
Where Amanda Fadenrecht's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 5 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| John Beauman Family Practice · Pueblo, CO | 29 | 80 |
| PARKVIEW MEDICAL CENTER, INC. | 17 | 23 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Laboratory Corporation Of America Clinical Laboratory · Englewood, CO | 40 | 97 |
| John Beauman Family Practice · Pueblo, CO | 22 | 56 |
| Patrick Timms Rheumatology · Pueblo, CO | 21 | 75 |
| PARKVIEW MEDICAL CENTER, INC. | 12 | 20 |
| Merilee Briggs-Mead Nurse Practitioner · Pueblo, CO | 12 | 19 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE